EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

No benefit of hydrocortisone, ascorbic acid, and thiamine in reducing mortality in adult sepsis patients: a systematic review and meta-analysis

Qing Zhao, Jianguo Xiao, Hui Liu

Emergency and Critical Care Medicine · 2022

DOI: 10.1097/ec9.0000000000000036 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Emergency and Critical Care Medicine, 2022. Verfasst von Qing Zhao und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Supplementation of corticosteroid, ascorbic acid and thiamine in adult septic patients remains controversial. We aimed to evaluate the efficacy and safety of hydrocortisone, ascorbic acid and thiamine (HAT) in adult septic patients.

Methods

Data search included Pumbed, EMBASE, and the Cochrane Library from inception to Sep, 2021. Only studies with classifications of sepsis and intravenous HAT treatment were included. Adult patients with sepsis (aged ≥18 years) were divided into 2 groups. The treatment group received HAT therapy, whereas the control group received standard care and/or intravenous hydrocortisone. The primary outcome was hospital mortality.

Results

Eleven studies including 4579 patients who fulfilled the predefined criteria were analyzed (6 randomized controlled trials [RCTs] and 5 clinical cohort studies). No hospital mortality reduction was demonstrated in patients treated with HAT when compared to the reference (OR: 0.99; 95% CI: 0.77 to 1.27; I 2 = 39%) group. Sequential organ failure assessment (SOFA) score decrement at 72hours was more significant in HAT-treated patients (mean difference [MD]: –1.23; 95% CI: –1.94 to –0.53; I 2 = 81%). There was no difference in the duration of vasopressor use between HAT-treated patients and controls (MD: –4.92; 95% CI: –24.38 to 14.53; I 2 = 97%). Statistical heterogeneity was noted with no sign of significant publication bias.

Conclusion

In adult sepsis and septic shock patients, HAT treatment failed to reduce mortality or shorten vasopressor duration, but reduced SOFA scores.

Zitieren

APA

Zhao, Q., Xiao, J., & Liu, H. (2022). No benefit of hydrocortisone, ascorbic acid, and thiamine in reducing mortality in adult sepsis patients: a systematic review and meta-analysis. Emergency and Critical Care Medicine. https://doi.org/10.1097/ec9.0000000000000036

Vancouver

Zhao Q, Xiao J, Liu H. No benefit of hydrocortisone, ascorbic acid, and thiamine in reducing mortality in adult sepsis patients: a systematic review and meta-analysis. Emergency and Critical Care Medicine. 2022. doi:10.1097/ec9.0000000000000036

BibTeX
@article{Zhao2022,
  author = {Zhao, Qing and Xiao, Jianguo and Liu, Hui},
  title = {No benefit of hydrocortisone, ascorbic acid, and thiamine in reducing mortality in adult sepsis patients: a systematic review and meta-analysis},
  journal = {Emergency and Critical Care Medicine},
  year = {2022},
  doi = {10.1097/ec9.0000000000000036}
}
Kostenlos starten →